A graduate of the Texas Tech University School of Medicine, Dr
This Hospira Pfizer formulation (NDC 0409-3977-03) is the same pharmaceutical-grade product used in hospitals, clinics, compounding pharmacies, and institutional settings nationwide
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context regarding genetic predispositions in key metabolic pathwaysincluding GLP1R rs6923761 and GIPR rs1800437 variantsthat relate to GLP-1 response potential, as well as variants in FTO and MC4R affecting metabolism and weight regulation
For this, one is reminded of the strong link between obesity and metabolic syndrome (MetS)
Without specific proof as to the exact cause of why a GLP-1 could cause a higher risk of developing NAION, we can hypothesize a bit and suggest hypovolemia and dehydration from perhaps weight loss, especially if the patient is getting a medication for hypertension and the weight loss has reduced the need for the hypertensive agent and thus the patient develops hypotension
